Kraig Biocraft Laboratories Inc (KBLB)

[Eskaminagaga]

I believe that you are looking at an old revision of the S-1

The S-1/A released on Jan 30, 2015 states:

We believe the results of our research and development efforts, if successful, will help increase our stock price and, therefore, reduce the number of shares we will need to put to Calm Seas in order to raise the full $7,500,000 in gross proceeds we are seeking to raise under the equity line financing under the Letter Agreement. In the event that we do not have positive results from our research and development during the 24 month term of the equity line financing, we believe it will be unlikely that we will raise the full $7,500,000 in gross proceeds under the equity line financing. In the event that we raise substantially less than the maximum proceeds that we expect to raise under the equity line financing by the expiration of its 24 month term, we will seek to raise additional capital from other investors.

And the newest revision on June 2, 2015 that went into effect removed that line completely.